Arzneimitteltherapie multimorbider Typ-2-Diabetes-Patienten
Crossref DOI link: https://doi.org/10.1007/s11428-016-0183-5
Published Online: 2017-01-25
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilke, T.
Hahn, P.
Groth, A.
Fuchs, A.
Maywald, U.
License valid from 2017-01-25